Novo Nordisk
NVO
#105
Rank
$162.51 B
Marketcap
$36.33
Share price
-1.52%
Change (1 day)
-49.84%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

Earnings for Novo Nordisk (NVO)

Earnings in 2025 (TTM): $20.96 Billion USD

According to Novo Nordisk's latest financial reports the company's current earnings are $47.70 Billion USD. , an increase over its 2024 earnings that were of $19.72 Billion USD. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Novo Nordisk from 1996 to 2025

Annual earnings

Year Earnings Change
2025 $20.96 B6.28%
2024 $19.72 B28.01%
2023 $15.40 B57.81%
2022 $9.76 B5.24%
2021 $9.27 B12.38%
2020 $8.25 B13.11%
2019 $7.29 B-3.45%
2018 $7.55 B1.88%
2017 $7.41 B4.3%
2016 $7.11 B10.32%
2015 $6.44 B7.47%
2014 $5.99 B3.4%
2013 $5.80 B19.09%
2012 $4.87 B15.58%
2011 $4.21 B16.58%
2010 $3.61 B25.66%
2009 $2.87 B10.68%
2008 $2.60 B55.82%
2007 $1.66 B7.02%
2006 $1.55 B19.05%
2005 $1.30 B10.55%
2004 $1.18 B
2002 $0.81 B-14.39%
2001 $0.95 B-52.82%
2000 $2.01 B250%
1999 $0.57 B31.21%
1998 $0.43 B34.31%
1997 $0.32 B11.46%
1996 $0.29 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
$10.19 B-51.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
$25.73 B 22.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
$7.69 B-63.27%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
$9.32 B-55.50%๐Ÿ‡บ๐Ÿ‡ธ USA